Guilherme Santoro‐Lopes, Érika Ferraz de Gouvêa, Rodrigo Carreira M. Monteiro, Rodrigo Castelo Branco, José Rodolfo Rocco, Márcia Halpern, Adriana Lúcia Pires Ferreira, Elaine Gama Pessoa de Araújo, Samanta T. Basto, Vinicius Gomes Silveira, Joaquim Ribeiro‐Filho – 21 January 2005 – Methicillin‐resistant Staphylococcus aureus (MRSA) is a frequent cause of infection after orthotopic liver transplantation (OLT). Colonization with MRSA is associated with a higher risk of infection. Previous studies have shown a high prevalence of MRSA colonization among OLT candidates.

Paolo R.O. Salvalaggio, Peter F. Whitington, Estella M. Alonso, Riccardo A. Superina – 21 January 2005 – We studied the impact of multiple bile duct anastomosis on the development of biliary complications after liver transplantation in children. A total of 101 patients received a primary liver transplant and were divided into 2 groups: those with a single bile duct (n = 77) and those with multiple bile ducts (n = 24). Mean follow‐up was 39.8 ± 20.8 months.

Arianeb Mehrabi, Markus Golling, Arash Kashfi, Tamara Boucsein, Peter Schemmer, Carsten N. Gutt, Jan Schmidt, Markus W. Büchler, Thomas W. Kraus – 21 January 2005 – Catecholamines are often administered during and after liver transplantation (LTx) to support systemic perfusion and to increase organ oxygen supply. Some vasoactive agents can compromise visceral organ perfusion.

Stefano Ginanni Corradini, Walter Elisei, Rosanna De Marco, Maria Siciliano, Massimo Iappelli, Francesco Pugliese, Franco Ruberto, Francesco Nudo, Renzo Pretagostini, Alessandro Bussotti, Gianluca Mennini, Annarita Eramo, Francesca Liguori, Manuela Merli, Adolfo Francesco Attili, Andrea Onetti Muda, Stefania Natalizi, Pasquale Berloco, Massimo Rossi – 21 January 2005 – A total of 44 donor/recipient perioperative and intraoperative variables were prospectively analyzed in 89 deceased‐donor liver transplantations classified as initial good graft function (IGGF) or initial poor graft function

Shimon Kusne, Jerry Smilack – 21 January 2005

Silvina E. Yantorno, Eva B. Varela, Sebastián R. Raffa, Valeria I. Descalzi, Maria L. Gomez Carretero, Daniel A. Pirola, Andres E. Ruf, Gretel I. Martinez Carabuz, Luis G. Podesta, Federico G. Villamil – 21 January 2005 – The mean time to peak absorption of cyclosporine (CsA) in liver transplant patients is approximately 2 hours, but in some patients the peak occurs later. The goal of this study was, therefore, to investigate the incidence of delayed absorption in 27 de novo liver transplant recipients receiving CsA ≥10 mg/kg/day (C2 monitoring) and in 15 maintenance patients.

21 January 2005

Virginie Fouquet, Arnaud Alves, Sophie Branchereau, Sophie Grabar, Dominique Debray, Emmanuel Jacquemin, Denis Devictor, Philippe Durand, Catherine Baujard, Monique Fabre, Danielle Pariente, Christophe Chardot, Bertrand Dousset, Pierre‐Philippe Massault, Denis Bernard, Didier Houssin, Olivier Bernard, Frédéric Gauthier, Olivier Soubrane – 21 January 2005 – The aim of this study was to review our experience in orthotopic liver transplantation (OLT) for biliary atresia (BA) in children and analyze the survival and prognostic factors, and long‐term outcome.

Paul J. Thuluvath – 21 January 2005

Thomas F. Baumert, Chun Yang, Peter Schürmann, Josef Köck, Christian Ziegler, Carsten Grüllich, Michael Nassal, T. Jake Liang, Hubert E. Blum, Fritz von Weizsäcker – 19 January 2005 – Hepatitis B virus (HBV) core promoter mutations have been implicated in the pathogenesis of fulminant hepatitis B. Due to the limited availability of primary human hepatocytes, the functional characterization of HBV mutants has been performed predominantly in transformed cells, which may not represent ideal model systems for studying virus–cell interactions.